BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11244501)

  • 1. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis.
    Kim YC; Song KS; Yoon G; Nam MJ; Ryu WS
    Oncogene; 2001 Jan; 20(1):16-23. PubMed ID: 11244501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts.
    Schuster R; Gerlich WH; Schaefer S
    Oncogene; 2000 Feb; 19(9):1173-80. PubMed ID: 10713705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional switch of viral protein HBx on cell apoptosis, transformation, and tumorigenesis in association with oncoprotein Ras.
    Wei W; Huang W; Pan Y; Zhu F; Wu J
    Cancer Lett; 2006 Nov; 244(1):119-28. PubMed ID: 16569476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
    Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.
    Chung TW; Lee YC; Kim CH
    FASEB J; 2004 Jul; 18(10):1123-5. PubMed ID: 15132991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
    Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
    EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.
    Park EH; Koh SS; Srisuttee R; Cho IR; Min HJ; Jhun BH; Lee YS; Jang KL; Kim CH; Johnston RN; Chung YH
    Cancer Gene Ther; 2009 May; 16(5):453-61. PubMed ID: 19096445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis.
    Slupianek A; Nieborowska-Skorska M; Hoser G; Morrione A; Majewski M; Xue L; Morris SW; Wasik MA; Skorski T
    Cancer Res; 2001 Mar; 61(5):2194-9. PubMed ID: 11280786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
    Oguey D; Dumenco LL; Pierce RH; Fausto N
    Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras pathway signals are required for notch-mediated oncogenesis.
    Fitzgerald K; Harrington A; Leder P
    Oncogene; 2000 Aug; 19(37):4191-8. PubMed ID: 10980592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner.
    Lara-Pezzi E; Roche S; Andrisani OM; Sánchez-Madrid F; López-Cabrera M
    Oncogene; 2001 Jun; 20(26):3323-31. PubMed ID: 11423982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways.
    Choi JA; Park MT; Kang CM; Um HD; Bae S; Lee KH; Kim TH; Kim JH; Cho CK; Lee YS; Chung HY; Lee SJ
    Oncogene; 2004 Jan; 23(1):9-20. PubMed ID: 14712206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphism of hepatitis B virus x gene in hepatocellular carcinoma patients and the biological effects of HBx gene with deletion varations on QSG7701 cells].
    Zhu PA; Tan DM; Peng ZT; Liu F; Song L
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):7-11. PubMed ID: 18226335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
    Ma NF; Lau SH; Hu L; Xie D; Wu J; Yang J; Wang Y; Wu MC; Fung J; Bai X; Tzang CH; Fu L; Yang M; Su YA; Guan XY
    Clin Cancer Res; 2008 Aug; 14(16):5061-8. PubMed ID: 18698024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
    Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
    Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector].
    Joo HY; Han KH; Ryu WS
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):371-80. PubMed ID: 12506241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.
    Kekulé AS; Lauer U; Weiss L; Luber B; Hofschneider PH
    Nature; 1993 Feb; 361(6414):742-5. PubMed ID: 8441471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
    Kohl NE; Ruley HE
    Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.